Literature DB >> 17713861

Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies.

Diaa K Shehab1, Khaled F Al-Jarallah, Adel M Al-Awadhi, Adeeba Al-Herz, Ibrahim Nahar, Mohammad Z Haider.   

Abstract

Low back pain (LBP) is a common medical problem. Interaction between genetic and environmental factors predisposes individuals to LBP even at an early age. Inflammatory back pain or spondylarthropathies include ankylosing spondylitis (AS), psoriatic arthritis (PSA), reactive arthritis enteropathic and undifferentiated arthropathies. Angiotensin-converting enzyme (ACE) plays an important role in circulatory homeostasis, physiology of vasculature and inflammation. The insertion-deletion (I/D) polymorphism of the ACE gene has been shown to determine the plasma and tissue levels of ACE especially in the synovial fluid. The aim of this study was to investigate an association between ACE gene I/D polymorphism and inflammatory back pain (spondylarthropathies) secondary to ankylosing spondylitis (AS), psoriatic arthritis, inflammatory bowel disease and undifferentiated spondylarthropathies. The prevalence of ACE gene I/D polymorphism genotypes was determined in 63 patients with inflammatory back pain by polymerase chain reaction (PCR) and compared with that in 111 healthy controls. Of the 63 patients studied, 45 (71.4%) were with AS, 13 (20.6%) were with PSA, 4 (6.3%) were with reactive arthropathy and 1 (1.6%) manifested undifferentiated arthropathy. There were 43 males and 20 females. Mean age of patients was 39.0+/-11.36 years, age at onset of spondylarthropathy was 27.7+/-7.49 years and disease duration was 10.3+/-7.74 months. The controls were selected to match with the patients group in terms of gender ratio, age and ethnicity. The ACE gene polymorphism showed an overall significant difference between patients and controls (p=0.050). When the ID and II genotype frequency was combined and compared with that for DD genotype amongst patient and control groups, a considerably higher incidence was detected for ID and II genotypes than the DD genotype in spondylarthropathy patients compared to that in the controls (p=0.036). This study showed a significant association of the I-allele of ACE gene I/D polymorphism with spondylarthropathy in Kuwaiti Arabs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713861     DOI: 10.1007/s11373-007-9203-1

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  6 in total

1.  Association of GSTM1, GSTT1, GSTP1-ILE105VAL and ACE I/D polymorphisms with ankylosing spondylitis.

Authors:  Esra Erkol İnal; Orhan Görükmez; Selma Eroğlu; Özlem Görükmez; Özlem Solak; Ali Topak; Tahsin Yakut
Journal:  Rheumatol Int       Date:  2015-07-18       Impact factor: 2.631

2.  Association of angiotensin-converting enzyme gene polymorphisms with Crohn's disease in a Chinese Han population.

Authors:  Jie Zhou; Sichang Zheng; Zhengting Wang; Rong Fan; Jielu Yuan; Jie Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Significant association between insertion/deletion polymorphism of the angiotensin-convertig enzyme gene and ankylosing spondylitis.

Authors:  Ahmet Inanır; Serbulent Yigit; Sengul Tural; Sibel Demir Ozturk; Songul Akkanet; Abdulkadir Habiboğlu
Journal:  Mol Vis       Date:  2012-07-26       Impact factor: 2.367

4.  Angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to psoriasis: a systematic review and meta-analysis.

Authors:  Mazaher Ramezani; Elisa Zavattaro; Masoud Sadeghi
Journal:  BMC Med Genet       Date:  2020-01-08       Impact factor: 2.103

5.  Computational Functional Genomics-Based AmpliSeq™ Panel for Next-Generation Sequencing of Key Genes of Pain.

Authors:  Dario Kringel; Sebastian Malkusch; Eija Kalso; Jörn Lötsch
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

6.  Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Authors:  Boglárka Soós; Miklós Fagyas; Ágnes Horváth; Edit Végh; Anita Pusztai; Monika Czókolyová; Alexandra Csongrádi; Attila Hamar; Zsófia Pethő; Nóra Bodnár; György Kerekes; Katalin Hodosi; Éva Szekanecz; Szilvia Szamosi; Sándor Szántó; Gabriella Szűcs; Zoltán Papp; Zoltán Szekanecz
Journal:  Front Med (Lausanne)       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.